blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3190126

EP3190126 - USE OF INTERLEUKIN-4 RECEPTOR (IL-4R) ANTIBODIES AND COMPOSITIONS THEREOF [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  17.05.2024
Database last updated on 28.09.2024
FormerExamination is in progress
Status updated on  16.02.2018
FormerRequest for examination was made
Status updated on  19.01.2018
FormerThe application has been published
Status updated on  15.06.2017
Most recent event   Tooltip17.05.2024Refusal of applicationpublished on 19.06.2024  [2024/25]
Applicant(s)For all designated states
Immunex Corporation
One Amgen Center Drive
Thousand Oaks, CA 91320-1799 / US
[2017/28]
Inventor(s)01 / MORRIS, Arvia E
4535 Thackeray Place NE
Seattle, WA 98105 / US
02 / PLUENNEKE, John D.
5816 Hickory Place
Parkville, MO 64152 / US
03 / ARMITAGE, Richard J
5840 Parkard Lane
Bainbridge Island, WA 98110 / US
04 / ESCOBAR, Jose Carlos
1707 East Beaverlake Drive SE
Sammarnish, WA 98075 / US
 [2017/28]
Representative(s)Uexküll & Stolberg
Partnerschaft von
Patent- und Rechtsanwälten mbB
Beselerstraße 4
22607 Hamburg / DE
[N/P]
Former [2017/28]Care, Alison, et al
Kilburn & Strode LLP
20 Red Lion Street
London WC1R 4PJ / GB
Application number, filing date16192152.325.05.2001
[2017/28]
Priority number, dateUS2000057980826.05.2000         Original published format: US 579808
US2000066534319.09.2000         Original published format: US 665343
US2001078593415.02.2001         Original published format: US 785934
US2001084781601.05.2001         Original published format: US 847816
[2017/28]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3190126
Date:12.07.2017
Language:EN
[2017/28]
Search report(s)(Supplementary) European search report - dispatched on:EP10.05.2017
ClassificationIPC:C07K16/28, A61K39/395, A61P19/02, A61P31/04, A61K38/17
[2017/28]
CPC:
C07K16/2866 (EP,US); A61K39/395 (US); A61P11/06 (EP);
A61P19/02 (EP); A61P31/04 (EP); A61P37/08 (EP);
C07K14/7155 (EP,US); C07K16/28 (US); A01K2217/05 (EP,US);
A61K2039/505 (EP,US); A61K38/00 (EP,US); C07K2317/21 (EP,US);
C07K2317/56 (EP,US); C07K2317/565 (US); C07K2317/76 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2018/08]
Former [2017/28]AT,  BE,  CH,  CY,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE,  TR 
TitleGerman:VERWENDUNG VON INTERLEUKIN-4 REZEPTOR (IL-4R) ANTIKÖRPERN UND ZUSAMMENSETZUNGEN DAVON[2017/28]
English:USE OF INTERLEUKIN-4 RECEPTOR (IL-4R) ANTIBODIES AND COMPOSITIONS THEREOF[2017/28]
French:UTILISATION D'ANTICORPS CONTRE LE RECEPTEUR D'INTERLEUKINE-4 (IL-4R) ET COMPOSITIONS CORRESPONDANTES[2017/28]
Examination procedure04.10.2016Date on which the examining division has become responsible
11.01.2018Amendment by applicant (claims and/or description)
11.01.2018Examination requested  [2018/08]
14.02.2018Despatch of a communication from the examining division (Time limit: M06)
24.08.2018Reply to a communication from the examining division
09.04.2019Observations by third parties
10.05.2019Observations by third parties
25.10.2019Despatch of a communication from the examining division (Time limit: M06)
29.05.2020Reply to a communication from the examining division
02.09.2020Observations by third parties
04.11.2020Despatch of a communication from the examining division (Time limit: M06)
09.06.2021Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
13.08.2021Reply to a communication from the examining division
08.10.2021Observations by third parties
02.11.2021Observations by third parties
22.12.2022Despatch of a communication from the examining division (Time limit: M06)
28.06.2023Reply to a communication from the examining division
21.08.2023Observations by third parties
05.02.2024Cancellation of oral proceeding that was planned for 04.06.2024
16.02.2024Despatch of communication that the application is refused, reason: substantive examination [2024/25]
16.02.2024Application refused, date of legal effect [2024/25]
04.06.2024Date of oral proceedings (cancelled)
Parent application(s)   TooltipEP01952133.5  / EP1283851
EP10185626.8  / EP2292665
EP15168899.1  / EP2990420
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
13.08.2021Request for further processing filed
13.08.2021Full payment received (date of receipt of payment)
Request granted
23.08.2021Decision despatched
Fees paidRenewal fee
04.10.2016Renewal fee patent year 03
04.10.2016Renewal fee patent year 04
04.10.2016Renewal fee patent year 05
04.10.2016Renewal fee patent year 06
04.10.2016Renewal fee patent year 07
04.10.2016Renewal fee patent year 08
04.10.2016Renewal fee patent year 09
04.10.2016Renewal fee patent year 10
04.10.2016Renewal fee patent year 11
04.10.2016Renewal fee patent year 12
04.10.2016Renewal fee patent year 13
04.10.2016Renewal fee patent year 14
04.10.2016Renewal fee patent year 15
04.10.2016Renewal fee patent year 16
10.05.2017Renewal fee patent year 17
11.05.2018Renewal fee patent year 18
15.05.2019Renewal fee patent year 19
14.05.2020Renewal fee patent year 20
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO9109059  (SCHERING CORP [US]) [A] 1-8 * page 17, line 12 - page 18, line 3; example -; claim - * * example - * * claim - *;
 [A]EP0604693  (SCHERING PLOUGH CORP [FR]) [A] 1-8 * claim - *;
 [A]WO9421282  (IMMUNEX CORP [US], et al) [A] 1-8 * example -; claim - * * claim - *;
 [A]WO9633735  (CELL GENESYS INC [US]) [A] 1-8 * page 15, line 9 - line 11; claims 1, 19, 20, 26, 27 * * claims 1,19,20,26,27 *;
 [A]WO9634096  (CELL GENESYS INC [US]) [A] 1-8 * page 14, line 16 - line 18; claims 1, 17, 18, 24, 25 * * claims 1,17,18,24,25 *;
 [A]WO0018932  (REGENERON PHARMA [US], et al) [A] 1-8 * figures 21-23; examples 10-13 ** figures 21-23 *;
 [A]  - S. ZURAWSKI ET AL., "The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor.", JOURNAL OF BIOLOGICAL CHEMISTRY, Baltimore, MD, USA, (19950609), vol. 270, no. 23, pages 13869 - 13878, XP000986235 [A] 1-8 * abstract *

DOI:   http://dx.doi.org/10.1074/jbc.270.23.13869
 [A]  - O. HULTGREN ET AL., "Staphylococcus aureus-induced septic arthritis and septic death is decreased in IL-4-deficient mice: role of IL-4 as promoter for bacterial growth.", THE JOURNAL OF IMMUNOLOGY, Baltimore, MD, USA, (19980515), vol. 160, no. 10, pages 5082 - 5087, XP002189479 [A] 1-8 * abstract *
by applicantUS4518584
 US4737462
 US4751180
 US4935233
 US4946778
 WO9103553
 US5011912
 US5017691
 WO9109059
 US5041381
 EP0464533
 WO9310151
 WO9318047
 WO9410308
 US5350683
 US5457035
 WO9611213
 US5510259
 US5545806
 WO9629408
 US5569825
 US5599905
 US5676940
 US5710023
 US5723118
 US5770429
 US5789237
 US5814318
 US5863537
 US5928904
 US5962269
 US6028176
 US6033688
    - YOKOTA ET AL., PROC. NATL. ACAD. SCI. USA, (1986), vol. 83, page 5894
    - NOMA ET AL., NATURE, (1986), vol. 319, page 640
    - GRABSTEIN ET AL., J. EXP. MED., (1986), vol. 163, page 1405
    - MOSIEY ET AL., CELL, (19891020), vol. 59, pages 335 - 348
    - IDZERDA ET AL., J. EXP. MED., (199003), vol. 171, pages 861 - 873
    - SATO ET AL., CURRENT OPINION IN CELL BIOLOGY, (1994), vol. 6, pages 174 - 179
    - ZURAWSKI ET AL., J. BIOL. CHEM., (1995), vol. 270, no. 23, page 13869
    - DE VRIES, J. ALLERGY CLIN. IMMUNOL, (199808), vol. 102, no. 2, page 165
    - CALLARD ET AL., IMMUNOLOGY TODAY, (199603), vol. 17, no. 3, page 108
    - YOUAKIM, A; M. AHDIEH, AM. J. PHYSIOL., vol. 276
    - GASTROINTEST. LIVERPHYSIOL., (1999), vol. 39, pages G1279 - G1288
    - MOSLEY ET AL., CELL, (19891020), vol. 59, pages 335 - 348
    - IDZERDA ET AL., J. EXP. MED., (199003), vol. 171, page 861
    - NEEDLEMAN; WUNSCH, J. MOL. BIOL., (1970), vol. 48, page 443
    - SMITH; WATERMAN, ADV. APPL. MATH., (1981), vol. 2, page 482
    - GRIBSKOV AND BURGESS, NUCL. ACIDS RES., (1986), vol. 14, page 6745
    - SCHWARTZ AND DAYHOFF,, Atlas of Protein Sequence and Structure, NATIONAL BIOMEDICAL RESEARCH FOUNDATION, (1979), pages 353 - 358
    - WALDER ET AL., GENE, (1986), vol. 42, page 133
    - BAUER ET AL., GENE, (1985), vol. 37, page 73
    - BIOTECHNIQUES, (198501), pages 12 - 19
    - HOPP ET AL., BIO/TECHNOLOGY, (1988), vol. 6, page 1204
    - ASHKENAZI ET AL., PNAS USA, (1991), vol. 88, page 10535
    - BYRN ET AL., NATURE, (1990), vol. 344, page 677
    - HOLLENBAUGH; ARUFFO, "Construction of Immunoglobulin Fusion Proteins", CURRENT PROTOCOLS IN IMMUNOLOGY, (1992), pages 10.19.1 - 10.19.11
    - BAUM ET AL., EMBO J., (1994), vol. 13, pages 3992 - 4001
    - LANDSCHULZ ET AL., SCIENCE, (1988), vol. 240, no. 1759
    - HOPPE ET AL., FEBS LETTERS, (1994), vol. 344, page 191
    - FANSLOW ET AL., SEMIN. IMMUNOL., (1994), vol. 6, pages 267 - 278
    - TAKESHITA ET AL., SCIENCE, (19920717), vol. 257, page 379
    - PARK ET AL., PROC. NATL. ACAD. SCI. USA, (1987), vol. 84, pages 1669 - 673
    - GLUZMAN ET AL., CELL, (1981), vol. 23, page 175
    - MCMAHAN ET AL., EMBO J., (1991), vol. 10, page 2821
    - RIECHMANN ET AL., NATURE, (1988), vol. 332, page 323
    - LIU ET AL., PNAS, (1987), vol. 84, page 3439
    - LARRICK ET AL., BIOFTECHNOLOGY, (1989), vol. 7, page 934
    - WINTER; HARRIS, TIPS, (199305), vol. 14, page 139
    - KORTT ET AL., PROTEIN ENGINEERING, (1997), vol. 10, page 423
    - BIRD, SCIENCE, (1988), vol. 242, page 423
    - HUSTON ET AL., PROC. NATL. ACAD. SCI. USA, (1988), vol. 85, page 5879
    - WARD ET AL., NATURE, (1989), vol. 334, page 544
    - FITCH ET AL., J. ALLERGY CLIN. IMMUNOL., (2001), vol. 107, no. 2, page S61
    - MULLER ET AL., J. MOL. BIOL., (1994), vol. 237, pages 423 - 436
    - PARK ET AL., J. EXP. MED., (1987), vol. 166, page 476
    - PRESTA ET AL., J. IMMUNOL., (1993), vol. 151, no. 5, pages 2623 - 2632
    - ADELROTH ET AL., J. ALLERGY CLIN. IMMUNOL, (2000), vol. 106, no. 2, pages 253 - 259
    - ZUND ET AL., J. BIOL. CHEM., (1996), vol. 271, no. 13, pages 7460 - 7464
    - MARCU ET AL., CELL, (1980), vol. 22, page 187
    - MARSH ET AL., GENE, (1984), vol. 32, pages 481 - 485
    - ADRA ET AL., GENE, (1987), vol. 60, pages 65 - 74
    - BOER ET AL., BIOCHEMICAL GENETICS, (1990), vol. 28, pages 299 - 308
    - TYBULEWICZ ET AL., CELL, (1991), vol. 65, pages 1153 - 1163
    - MANSOUR ET AL., NATURE, (1988), vol. 336, pages 348 - 352
    - MCMAHON, A. P.; BRADLEY, A., CELL, (1990), vol. 62, pages 1073 - 1085
    - E. J. ROBERTSON,, Teratocarcinomas and Embryonic Stem Cells: a Practical Approach, IRL PRESS, (1987), pages 71 - 112
    - HASTY ET AL., NATURE, (1991), vol. 350, pages 243 - 246
    - LAIRD ET AL., NUCLEIC ACIDS RES., (1991), vol. 19, page 4293
    - A. BRADLEY, Teratocarcinomas and Embryonic Stem Cells: a Practical Approach, IRL PRESS, (1987), pages 113 - 151
    - CHEN ET AL., IMMUNOL, (1993), vol. 5, pages 647 - 656
    - TAYLOR ET AL., INT. IMMUNOL., (1994), vol. 6, pages 579 - 591
    - TAYLOR ET AL., NUCLEIC ACIDS RES., (1992), vol. 20, pages 6287 - 6295
    - CHEN ET AL., EMBO J., (1993), vol. 12, pages 811 - 820
    - FISHWILD ET AL., NATURE BIOTECHNOLOGY, (1996), vol. 14, pages 845 - 851
    - OI; HERTZENBERG, "Immunoglobulin Producing Hybrid Cell Lines", OI; HERTZENBERG, MISHELL AND SHIIGI,, Selected Methods In Cellular Immunology, FREEMAN, (1980), pages 357 - 372
    - MORRIS ET AL., J. BIOL. CHEM., (1999), vol. 274, pages 418 - 423
    - MADARA, J.; K. DHARMSATHAPHORN, J. CELL BIOL., (1985), vol. 101, pages 2124 - 2133
    - MADARA, J.; J. STAFFORD, J. CLIN. INVEST., (1989), vol. 83, pages 724 - 727
    - YOUAKIM, A.; M. AHDIEH, AM. J. PHYSIOL., vol. 276
    - GASTROINTEST. LIVER PHYSIOL., (1999), vol. 39, pages G1279 - G1288
    - ELLISON ET AL., DNA, (1981), vol. 1, no. 1, pages 11 - 18
otherEP2990420
 WO9633735
 WO9634096
    - "Epitope Mapping", Ed Harlow and David Lane, Antibodies, A Laboratory Manual, Cold Spring Harbor Laboratory Press, (19980000), page 590, XP055586163
    - Ganesh N Sivalingam; Adrian J Shepherd, "An analysis of beta-cell epitope discontinuity", Molecular Immunology, vol. 51, no. 3-4, pages 304 - 309, XP028503029

DOI:   http://dx.doi.org/10.1016/j.molimm.2012.03.030
    - ZURAWSKI et al., "The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor", J. Biol. Chem., (19950000), vol. 270, doi:10.1074/jbc.270.23.13869, pages 13869 - 13878, XP002010894

DOI:   http://dx.doi.org/10.1074/jbc.270.23.13869
    - Keegan A. D., "IL-4 Receptor", Cytokine Reference, Academic Press, (20000101), pages 1471 - 1480, XP093079229
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.